{
    "root": "8f7897be-98f0-413b-a5ca-bcbdafcf1192",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Dicyclomine Hydrochloride",
    "value": "20250319",
    "ingredients": [
        {
            "name": "DICYCLOMINE HYDROCHLORIDE",
            "code": "CQ903KQA31"
        },
        {
            "name": "ACACIA",
            "code": "5C5403N26O"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "ALUMINUM OXIDE",
            "code": "LMI26O6933"
        }
    ],
    "indications": "dicyclomine hydrochloride indicated treatment patients functional bowel/irritable bowel syndrome .",
    "contraindications": "must adjusted individual patient needs .",
    "warningsAndPrecautions": "dicyclomine hydrochloride tablets usp , 20 mg 20 mg blue , round , flat-faced , beveled edge tablets , debossed lan 1282 , supplied bottles 100 , 500 1000 tablets . prevent fading , avoid exposure direct sunlight . store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . dispense well-closed container defined usp . bottles 20 tablets : ndc 68788-7811-2 bottles 30 tablets : ndc 68788-7811-3 bottles 60 tablets : ndc 68788-7811-6 bottles 90 tablets : ndc 68788-7811-9",
    "adverseReactions": "dicyclomine hydrochloride contraindicated infants less 6 months age [ ( 8.4 ) ] , nursing mothers [ ( 8.3 ) ] , patients : •unstable cardiovascular status acute hemorrhage •myasthenia gravis [ ( 5.4 ) ] •glaucoma [ ( 6.3 ) ( 7.1 ) ] •obstructive uropathy [ ( 5.8 ) ] •obstructive disease gastrointestinal tract [ ( 5.5 ) ] •severe ulcerative colitis [ ( 5.7 ) ] •reflux esophagitis",
    "indications_original": "Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome.",
    "contraindications_original": "Dosage must be adjusted to individual patient needs.",
    "warningsAndPrecautions_original": "Dicyclomine Hydrochloride Tablets USP, 20 mg\n                  \n                  20 mg blue, round, flat-faced, beveled edge tablets, debossed LAN over 1282, supplied in bottles of 100, 500 and 1000 tablets. To prevent fading, avoid exposure to direct sunlight. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a well-closed container as defined in the USP.\n                  Bottles of 20 tablets: NDC 68788-7811-2\n                  Bottles of 30 tablets: NDC 68788-7811-3\n                  Bottles of 60 tablets: NDC 68788-7811-6\n                  Bottles of 90 tablets: NDC 68788-7811-9",
    "adverseReactions_original": "Dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see Use in Specific Populations (8.4)], nursing mothers [see Use in Specific Populations (8.3)], and in patients with:\n                  \n                     \n                        •unstable cardiovascular status in acute hemorrhage\n                     \n                        •myasthenia gravis [see Warnings and Precautions (5.4)]\n                     \n                     \n                        •glaucoma [see Adverse Reactions (6.3) and Drug Interactions (7.1)]\n                     \n                     \n                        •obstructive uropathy [see Warnings and Precautions (5.8)]\n                     \n                     \n                        •obstructive disease of the gastrointestinal tract [see Warnings and Precautions (5.5)]\n                     \n                     \n                        •severe ulcerative colitis [see Warnings and Precautions (5.7)]\n                     \n                     \n                        •reflux esophagitis"
}